Lauren B Becnel1,2, Smita Hastak3, Wendy Ver Hoef3, Robert P Milius4, MaryAnn Slack5, Diane Wold1, Michael L Glickman6, Boris Brodsky5, Charles Jaffe7, Rebecca Kush1, Edward Helton8. 1. Clinical Data Interchange Standards Consortium, Austin, TX, USA. 2. Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA. 3. Samvit Solutions LLC, Reston, VA, USA. 4. National Marrow Donor Program, Minneapolis, MN, USA. 5. Food and Drug Administration Office of Strategic Programs, Silver Spring, MD, USA. 6. Computer Network Architects Inc. and ISO/TC 215 Health Informatics, Rockville, MD, USA. 7. HL7 (Health Level 7 International), Ann Arbor, MI, USA. 8. National Cancer Institute, Rockville, MD, USA.
Abstract
BACKGROUND: It is critical to integrate and analyze data from biological, translational, and clinical studies with data from health systems; however, electronic artifacts are stored in thousands of disparate systems that are often unable to readily exchange data. OBJECTIVE: To facilitate meaningful data exchange, a model that presents a common understanding of biomedical research concepts and their relationships with health care semantics is required. The Biomedical Research Integrated Domain Group (BRIDG) domain information model fulfills this need. Software systems created from BRIDG have shared meaning "baked in," enabling interoperability among disparate systems. For nearly 10 years, the Clinical Data Standards Interchange Consortium, the National Cancer Institute, the US Food and Drug Administration, and Health Level 7 International have been key stakeholders in developing BRIDG. METHODS: BRIDG is an open-source Unified Modeling Language-class model developed through use cases and harmonization with other models. RESULTS: With its 4+ releases, BRIDG includes clinical and now translational research concepts in its Common, Protocol Representation, Study Conduct, Adverse Events, Regulatory, Statistical Analysis, Experiment, Biospecimen, and Molecular Biology subdomains. INTERPRETATION: The model is a Clinical Data Standards Interchange Consortium, Health Level 7 International, and International Standards Organization standard that has been utilized in national and international standards-based software development projects. It will continue to mature and evolve in the areas of clinical imaging, pathology, ontology, and vocabulary support. BRIDG 4.1.1 and prior releases are freely available at https://bridgmodel.nci.nih.gov .
BACKGROUND: It is critical to integrate and analyze data from biological, translational, and clinical studies with data from health systems; however, electronic artifacts are stored in thousands of disparate systems that are often unable to readily exchange data. OBJECTIVE: To facilitate meaningful data exchange, a model that presents a common understanding of biomedical research concepts and their relationships with health care semantics is required. The Biomedical Research Integrated Domain Group (BRIDG) domain information model fulfills this need. Software systems created from BRIDG have shared meaning "baked in," enabling interoperability among disparate systems. For nearly 10 years, the Clinical Data Standards Interchange Consortium, the National Cancer Institute, the US Food and Drug Administration, and Health Level 7 International have been key stakeholders in developing BRIDG. METHODS: BRIDG is an open-source Unified Modeling Language-class model developed through use cases and harmonization with other models. RESULTS: With its 4+ releases, BRIDG includes clinical and now translational research concepts in its Common, Protocol Representation, Study Conduct, Adverse Events, Regulatory, Statistical Analysis, Experiment, Biospecimen, and Molecular Biology subdomains. INTERPRETATION: The model is a Clinical Data Standards Interchange Consortium, Health Level 7 International, and International Standards Organization standard that has been utilized in national and international standards-based software development projects. It will continue to mature and evolve in the areas of clinical imaging, pathology, ontology, and vocabulary support. BRIDG 4.1.1 and prior releases are freely available at https://bridgmodel.nci.nih.gov .
Authors: Egon L Willighagen; Andra Waagmeester; Ola Spjuth; Peter Ansell; Antony J Williams; Valery Tkachenko; Janna Hastings; Bin Chen; David J Wild Journal: J Cheminform Date: 2013-05-08 Impact factor: 5.514
Authors: Joshua A Hirsch; Thabele M Leslie-Mazwi; Gregory N Nicola; Robert M Barr; Jacqueline A Bello; William D Donovan; Raymond Tu; Mark D Alson; Laxmaiah Manchikanti Journal: J Neurointerv Surg Date: 2014-03-03 Impact factor: 5.836
Authors: Robert R Freimuth; Elaine T Freund; Lisa Schick; Mukesh K Sharma; Grace A Stafford; Baris E Suzek; Joyce Hernandez; Jason Hipp; Jenny M Kelley; Konrad Rokicki; Sue Pan; Andrew Buckler; Todd H Stokes; Anna Fernandez; Ian Fore; Kenneth H Buetow; Juli D Klemm Journal: J Am Med Inform Assoc Date: 2012-06-28 Impact factor: 4.497
Authors: Bethan Yates; Bryony Braschi; Kristian A Gray; Ruth L Seal; Susan Tweedie; Elspeth A Bruford Journal: Nucleic Acids Res Date: 2016-10-30 Impact factor: 16.971
Authors: Barbara J Kenner; Natalie D Abrams; Suresh T Chari; Bruce F Field; Ann E Goldberg; William A Hoos; David S Klimstra; Laura J Rothschild; Sudhir Srivastava; Matthew R Young; Vay Liang W Go Journal: Pancreas Date: 2021-08-01 Impact factor: 3.243
Authors: Rhonda Facile; Erin Elizabeth Muhlbradt; Mengchun Gong; Qingna Li; Vaishali Popat; Frank Pétavy; Ronald Cornet; Yaoping Ruan; Daisuke Koide; Toshiki I Saito; Sam Hume; Frank Rockhold; Wenjun Bao; Sue Dubman; Barbara Jauregui Wurst Journal: JMIR Med Inform Date: 2022-01-27
Authors: Andrey Fedorov; William J R Longabaugh; David Pot; David A Clunie; Steve Pieper; Hugo J W L Aerts; André Homeyer; Rob Lewis; Afshin Akbarzadeh; Dennis Bontempi; William Clifford; Markus D Herrmann; Henning Höfener; Igor Octaviano; Chad Osborne; Suzanne Paquette; James Petts; Davide Punzo; Madelyn Reyes; Daniela P Schacherer; Mi Tian; George White; Erik Ziegler; Ilya Shmulevich; Todd Pihl; Ulrike Wagner; Keyvan Farahani; Ron Kikinis Journal: Cancer Res Date: 2021-06-15 Impact factor: 12.701